HEBERPROT-P, a Cuban medicine for patients with advanced diabetic foot ulcers and a high risk of amputation, has revolutionized the treatment of this condition. Manuel Raices, a member of the research team for HEBERPROT-P, told Prensa Latina that the drug was registered in 2006 and since then it has benefited 16,000 patients from several nations.
Read More
